Literature DB >> 19575552

Positive correlations between serum and plasma matrix metalloproteinase (MMP)-2 or MMP-9 levels in disease conditions.

Raquel F Gerlach, Cesar A Meschiari, Andrea M Marcaccini, Ana C T Palei, Valeria C Sandrim, Ricardo C Cavalli, Jose E Tanus-Santos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19575552     DOI： 10.1515/CCLM.2009.203

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN： 1434-6621            Impact factor:   3.694


× No keyword cloud information.
  10 in total

1.  Serum or Plasma Matrix Metalloproteinase (MMP)-9 Levels and Cardiovascular Diseases.

Authors:  Indiara V Santana; Jose E Tanus-Santos
Journal:  J Cardiovasc Transl Res       Date:  2018-08-21       Impact factor: 4.132

2.  Matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) in preoperative serum as independent prognostic markers in patients with colorectal cancer.

Authors:  Vesna V Dragutinović; Nevena V Radonjić; Nataša D Petronijević; Svetislav B Tatić; Ivan B Dimitrijević; Nebojša S Radovanović; Zoran V Krivokapić
Journal:  Mol Cell Biochem       Date:  2011-05-04       Impact factor: 3.396

3.  Translating molecular medicine into clinical tools: doomed to fail by neglecting basic preanalytical principles.

Authors:  Klaus Jung; Ferdinando Mannello; Michael Lein
Journal:  J Transl Med       Date:  2009-10-14       Impact factor: 5.531

4.  Pre-treatment gelatinases' serum levels and post-treatment changes in laryngeal cancer patients.

Authors:  G Tsiropoulos; T Papadas; Ie Triantaphyllidou; S Naxakis; K Markou; S Triaridis; I Vital; P Goumas; Dh Vynios
Journal:  Hippokratia       Date:  2013-07       Impact factor: 0.471

5.  Reappraisal of quantitative gel zymography for matrix metalloproteinases.

Authors:  Tommaso Prescimone; Danika Tognotti; Chiara Caselli; Manuela Cabiati; Andrea D'Amico; Silvia Del Ry; Daniela Giannessi
Journal:  J Clin Lab Anal       Date:  2014-03-19       Impact factor: 2.352

6.  Serum matrix metalloproteinase 9 and colorectal neoplasia: a community-based evaluation of a potential diagnostic test.

Authors:  S Wilson; S Damery; D D Stocken; G Dowswell; R Holder; S T Ward; V Redman; M J Wakelam; J James; F D R Hobbs; T Ismail
Journal:  Br J Cancer       Date:  2012-03-20       Impact factor: 7.640

7.  Circulating Transforming Growth Factor-β and Aortic Dilation in Patients with Repaired Congenital Heart Disease.

Authors:  Yiu-Fai Cheung; Pak-Cheong Chow; Edwina Kam-Fung So; Koon-Wing Chan
Journal:  Sci Rep       Date:  2019-01-17       Impact factor: 4.379

Review 8.  The behavior of matrix metalloproteinases and their inhibitors in colorectal cancer.

Authors:  László Herszényi; István Hritz; Gábor Lakatos; Mária Zsófia Varga; Zsolt Tulassay
Journal:  Int J Mol Sci       Date:  2012-10-16       Impact factor: 5.923

9.  Serum MMP-8: a novel indicator of left ventricular remodeling and cardiac outcome in patients after acute myocardial infarction.

Authors:  Marie Fertin; Gilles Lemesle; Annie Turkieh; Olivia Beseme; Maggy Chwastyniak; Philippe Amouyel; Christophe Bauters; Florence Pinet
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

10.  Levels of matrix metalloproteinases differ in plasma and serum - aspects regarding analysis of biological markers in cancer.

Authors:  Andreas Jonsson; Claes Hjalmarsson; Peter Falk; Marie-Lois Ivarsson
Journal:  Br J Cancer       Date:  2016-05-17       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.